Protein-Protein Interactions in Translesion Synthesis

Area of Science:

• Molecular Biology
• Cancer Biology
• Drug Discovery

Background:

• Translesion synthesis (TLS) is a DNA damage tolerance mechanism essential for replicating cells to bypass DNA lesions.
• TLS allows replication to proceed past damaged DNA, but increases mutation rates.
• Recent research highlights TLS's critical role in cancer cell survival during genotoxic chemotherapy and in developing acquired resistance.

Purpose of the Study:

• To review the significance of TLS in cancer.
• To analyze critical protein-protein interactions (PPIs) within the TLS machinery.
• To explore the structural features of TLS PPIs and their potential as drug targets.

Main Methods:

• Literature review of TLS mechanisms in cancer.
• Analysis of protein-protein interaction interfaces in TLS.
• Evaluation of the druggability of key TLS PPIs.

Main Results:

• TLS is crucial for cancer cells to survive chemotherapy-induced DNA damage.
• TLS contributes to the development of acquired resistance to anti-cancer drugs.
• Specific protein-protein interactions within TLS complexes present potential therapeutic targets.

Conclusions:

• TLS is a vital mechanism for cancer cell survival and drug resistance.
• Targeting TLS protein-protein interactions is a promising strategy for novel cancer therapeutics.
• Understanding TLS PPIs' structural features is key to developing effective small molecule inhibitors.